New vaccine strategies based on recombinant vector

In our group, we are working on developing new vaccine strategies using recombinant viral vectoes such as adenovirus. These vectors are used to express antigens from viral disease such as peste des petits ruminants or bluetongue. The immune response induced by these vaccines is assessed in animal models and in sheep. The most promising constructs are then tested in challenge experiments to determine their protective capacity.